Raymond James & Associates Accelerate Diagnostics, Inc Transaction History

Raymond James & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$0.64 - $1.03 $320 - $515	-500 Reduced 2.86%	16,999 $13,000
Q3 2022 Oct 25, 2022	BUY	$1.01 - $17.0 $17,673 - $297,483	17,499 New	17,499 $27,000
Q3 2018 Nov 14, 2018	SELL	$20.4 - $24.6 $215,362 - $259,702	-10,557 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$19.02 - $24.95 $534,157 - $700,695	-28,084 Reduced 72.68%	10,557 $235,000
Q1 2018 May 14, 2018	BUY	$22.55 - $29.9 $7,892 - $10,465	350 Added 0.91%	38,641 $883,000
Q4 2017 Feb 14, 2018	BUY	$18.0 - $30.0 $292,482 - $487,470	16,249 Added 73.72%	38,291 $1 Million
Q3 2017 Nov 13, 2017	BUY	$21.1 - $25.15 $100,815 - $120,166	4,778 Added 27.68%	22,042 $495,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,264	17,264 $472,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.